Latest SEC filings for BioNTech SE (BNTX) explained in plain English: insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). Sourced directly from SEC EDGAR.
Poetting Sierk, listed as Chief Operating Officer at BioNTech SE, reported an open-market sale of 50,000 BNTX shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.
Poetting Sierk filed a Form 144 with the SEC indicating intent to sell BNTX (BioNTech SE) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.
Medine GmbH filed a Form 144 with the SEC indicating intent to sell BNTX (BioNTech SE) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.
Tureci Ozlem filed a Form 144 with the SEC indicating intent to sell BNTX (BioNTech SE) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.
Medine GmbH filed a Form 144 with the SEC indicating intent to sell BNTX (BioNTech SE) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.
Jeggle Helmut Wolfgang filed a Form 144 with the SEC indicating intent to sell BNTX (BioNTech SE) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.
ATHOS KG filed a Form 144 with the SEC indicating intent to sell BNTX (BioNTech SE) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.
Medine GmbH filed a Form 144 with the SEC indicating intent to sell BNTX (BioNTech SE) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.
Tureci Ozlem filed a Form 144 with the SEC indicating intent to sell BNTX (BioNTech SE) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.
Jeggle Helmut Wolfgang filed a Form 144 with the SEC indicating intent to sell BNTX (BioNTech SE) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.
ATHOS KG filed a Form 144 with the SEC indicating intent to sell BNTX (BioNTech SE) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.
ATHOS KG filed a Form 144 with the SEC indicating intent to sell BNTX (BioNTech SE) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.
Jeggle Helmut Wolfgang filed a Form 144 with the SEC indicating intent to sell BNTX (BioNTech SE) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.
Richardson Ryan filed a Form 144 with the SEC indicating intent to sell BNTX (BioNTech SE) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.
Medine GmbH filed a Form 144 with the SEC indicating intent to sell BNTX (BioNTech SE) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.